Home

Cohance Lifesciences Ltd EPS

Image

Cohance Lifesciences Ltd

NSE: COHANCE

EPS

₹ 7

Last updated on: Jul 08, 2025

Key Highlights

  • The Earning per Share of Cohance Lifesciences Ltd is ₹ 7 as of 08 Jul 25 .
  • The earning per share of Cohance Lifesciences Ltd changed from ₹ 4.74 to ₹ 1.65 over 8 quarters. This represents a CAGR of -41.00% .

Historical Earning per Share of Cohance Lifesciences Ltd

No data available

* All values are in

Company Fundamentals for Cohance Lifesciences Ltd

Market Cap

37,891 Cr

EPS

7.0

P/E Ratio (TTM)

145.5

P/B Ratio (TTM)

22.8

Day’s High

1016.2

Day’s Low

980.5

DTE

0.2

ROE

15.8

52 Week High

1359.0

52 Week Low

789.1

ROCE

14.1

Market Price of Cohance Lifesciences Ltd

1M

1Y

3Y

5Y

Monitoring Cohance Lifesciences Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
08 Jul 2025990.45
07 Jul 20251018.75
04 Jul 20251043.8
03 Jul 20251006.65
02 Jul 2025967.4
01 Jul 2025960.35
30 Jun 2025966.65
27 Jun 2025944.05
26 Jun 20251002.1
25 Jun 2025980

SWOT Analysis Of Cohance Lifesciences Ltd

Strength

2

che

Weakness

1

che

Opportunity

0

che

Threats

0

che

BlinkX Score for Cohance Lifesciences Ltd

Asset Value vs Market Value of Cohance Lifesciences Ltd

Market Value

38,974

Asset Value

Value addition

77.9 X

494

* All values are in ₹ crores

Competitive Comparison of EPS

Company
leftMarket Capright
Cohance Lifesciences Ltd38974
Sun Pharmaceutical Industries Ltd403040
Divis Laboratories Ltd182722
Cipla Ltd122033
Torrent Pharmaceuticals Ltd113394
Dr Reddys Laboratories Ltd109334

Historical Market Cap of Cohance Lifesciences Ltd

No data available

* All values are in crore

Historical Revenue of Cohance Lifesciences Ltd

No data available

* All values are in crore

Historical EBITDA of Cohance Lifesciences Ltd

No data available

* All values are in crore

Historical Net Profit of Cohance Lifesciences Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Cohance Lifesciences Ltd News Hub

Suven Pharmaceuticals consolidated net profit declines 49.61% in the June 2024 quarter

Net profit of Suven Pharmaceuticals declined 49.61% to Rs 60.77 crore in the quarter ended June 2024

Read more

09 Aug 24

Suven Pharmaceuticals to hold board meeting

Suven Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 9 August 2024.

Read more

06 Aug 24

Suven Pharmaceuticals appoints Vivek Sharma as new Executive Chairman

Suven Pharmaceuticals announced the appointment of Vivek Sharma as the new Executive Chairman, effec

Read more

19 Sept 24

Board of Suven Pharmaceuticals approves change in Executive Chairperson

The Board of Suven Pharmaceuticals at its meeting held on 19 September 2024 has taken on record the

Read more

19 Sept 24

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for EPS of Cohance Lifesciences Ltd

What is the EPS of Cohance Lifesciences Ltd stock?

The Earnings Per Share (EPS) of Cohance Lifesciences Ltd is 7.0. An EPS is the amount of net income attributed to each share of a common stock.

How is Cohance Lifesciences Ltd EPS calculated?

The EPS of Cohance Lifesciences Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Cohance Lifesciences Ltd report its EPS?

Cohance Lifesciences Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Cohance Lifesciences Ltd EPS?

Factors that influence the EPS of Cohance Lifesciences Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Cohance Lifesciences Ltd EPS growth indicate future performance?

Yes, consistent growth in Cohance Lifesciences Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions